The AJMC® Migraine compendium is a comprehensive resource for clinical news and expert insights for the recurring type of headache, which is accompanied by side effects.
April 20th 2023
This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Aspirin Effective in Treating Acute Migraine, Preventing Recurrent Migraine, Review Finds
December 4th 2019Aspirin, in high doses from 900 to 1300 mg, was shown to be an effective and safe treatment option for acute migraine headaches, with further research showing its potential efficacy in preventing recurrent migraine headaches through lower doses of 81 to 325 mg, according to findings of a review.
Read More
Case Study Indicates Link Between Stroke and Migraine
November 30th 2019A recent case study of a patient with a history of migraine with visual aura revealed a pathophysiological link between stroke and migraine, demonstrating the need for additional research that links migrainous infarction (MI) and stroke-related migraine.
Read More
Researchers Uncover Mechanism Behind Relationship of Migraine, Opioid-Induced Pain in Mice
November 22nd 2019The link between prolonged opioid treatment and an increased frequency, severity of migraines has been attributed to the discovery of a peptide confirmed in mice that distinguishes the relationship of migraine pain and opioid-induced hyperalgesia (OIH), according to study findings.
Read More
Longitudinal Assessment Reveals Cost-Effectiveness of Erenumab for Treatment of Migraine
November 17th 2019A longitudinal assessment of the cost-effectiveness of erenumab as a treatment for migraine exhibited higher patient utility when compared with placebo, according to study findings published this week.
Read More
Migraine Attack in Response to Nitroglycerin Showed Greater Cardiovascular Responses, Study Finds
November 16th 2019A study investigating the cardiovascular responses to nitroglycerin in migraine found that migraineurs who developed a migraine-like attack in response to nitroglycerin demonstrated greater systemic cardiovascular responses compared with non-headache controls.
Read More
Study Results Suggest Long-Term Safety of Erenumab for Treating Migraine
November 9th 2019An interim analysis of migraine drug erenumab showed that it continued to be safe and well-tolerated, with an adverse event profile consistent with those found in shorter-term placebo-controlled studies.
Read More
Intranasal Lidocaine May Be Effective Acute Migraine Treatment, Study Finds
November 2nd 2019Intranasal lidocaine may be a useful option for patients with an acute migraine, according to a study which showed the drug had a high success rate, low pain intensity, infrequent need for rescue medicine, and tolerable adverse events.
Read More
Evaluating Migraine Advancements Through a Payer's Perspective
November 1st 2019Panelists YuQian Liu, PharmD, and Carly Rodriguez, PharmD, FAMCP, discussed migraine treatment advances, available real-world evidence, and migraine management strategies with moderator Charles Collins, MS, MBA, at AMCP Nexus 2019 in National Harbor, Maryland.
Read More
Fremanezumab was shown to clinically improve headache-related disability outcomes in patients with either chronic or episodic migraines and reported inadequate response to 2 to 4 classes of migraine preventative medications, according to a study presented at the 144th Annual Meeting of the American Neurological Association.
Read More
Population-Based Study Identifies Numerous Risk Factors for Migraine
October 19th 2019A recent study presented at the American Neurological Association meeting identified vascular and nonvascular risk factors associated with migraine in a population-based study in an effort to help identify targets for reducing migraine-related disability.
Read More
Patients Who Have Aura With Migraine Have Smaller Brain Structures Than Healthy Subjects
October 11th 2019A recent study sought to identify possible differences in subcortical structures between patients who have migraine with aura (MwA) and healthy subjects, and also to determine the correlations between the characteristics of migraine aura and the volumes of subcortical structures.
Read More
Elevated C-Reactive Protein Levels Linked With Migraines Occurring 15 Days or More, or With Aura
October 2nd 2019Researchers said the previous results on high sensitivity C-reactive protein and migraine are mixed, and the relationship to insomnia limited; the aim of this study was to evaluate the cross-sectional association between hs-CRP and types of headache, and to see whether the relationship to insomnia could be reproduced.
Read More
IgG Elimination Diet Plus Probiotics May Be Beneficial for Patients With Both Migraine and IBS
September 28th 2019An immunoglobulin G (IgG) elimination diet combined with probiotics may be effective and beneficial for patients with both migraine and irritable bowel syndrome (IBS), according to a recent study,
Read More
Dr Abraham Nagy Highlights the Need to Educate on the Impact Headaches Can Have
September 20th 2019Migraines and cluster headaches can have devastating consequences on people’s lives, and there is a need to educate the public about the impact these disorders can have, said Abraham Nagy, MD, chair of neurology at University of Las Vegas and director of Nevada Headache Institute.
Watch
Study Examines Links Between Weather, Pollution, Migraines
September 7th 2019A study investigating the effects of weather and air pollution on migraine found that higher relative humidity was associated with higher odds of migraines during warmer seasons. Traffic-related pollutants was linked with migraines in colder weather.
Read More